Top 15 Immuno-Oncology Collaborations

The top 15 immuno-oncology collaborations' total value of all 15 ranked collaborations is approximately $30 billion.

Win More Biologics Development Battles with Early Stability Analysis

Broadcast Date: June 21st, 2017 Time: 11:00 am ET, 8:00 am PT Biophysical and chemical properties are critical factors that can dictate success or failure in...

Fear in Mind: Coping Mechanism Identified in New Brain Region

Scientists at Texas A&M University have identified a region in the brain that is involved in inhibiting fear, and which could feasibly lead to...

Top 7 CROs

The top public CRO ranked on this list is based outside the U.S., reflecting the industry’s desire to cut research costs by outsourcing the work overseas.

Anti-Obesity “Biochemical Cigarette” Exploits Body’s Responses to Cold and Smoking

Researchers in Europe and Australia have developed an anti-obesity “chemical cigarette” that exploits the body’s natural responses to both cold exposure and smoking. The...

Softening Up Chemo-Resistant Cancer Cells

Scientists at the University of California San Diego (UCSD) have identified a gene that is involved in controlling the sensitivity of cancer cells to...

Targeting Glioblastoma by Depriving Brain Cancer Cells of Cholesterol

Study identified a metabolic vulnerability in the aggressive and incurable brain cancer glioblastoma and shown how it can potentially be exploited for therapy.

Hope for Autism Lies in Century-Old Drug

Testing a new theory, researchers have used a newly discovered function of an old drug to restore cell communications in a mouse model of autism, reversing symptoms of the disorder.

Oligosaccharide Analysis Using High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection

Broadcast Date: December 4th, 2014 Time: 11:00 am ET, 8:00 am PT Oligosaccharide profiling of biopharmaceutical and other glycoprotein products remains challenging for scientists who report...

Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes

A large Phase III trial, the Impassion130 trial, has produced results supporting the use of chemotherapy plus immunotherapy as first-line treatment in certain patients...

Recently Featured

Stay Connected

Scroll Up